Search results for "Highlights"
Individualized nutrition therapy recommended for diabetes, prediabetes
Adults with diabetes should be referred to individualized, diabetes-focused medical nutrition therapy, while overweight or obese adults with prediabetes should be referred to an intensive lifestyle intervention program and/or medical nutritional therapy, according to the consensus report from the American Diabetes Association.
https://diabetes.acponline.org/archives/2019/05/10/1.htm
10 May 2019
Expert panel recommends target ranges for continuous glucose monitoring data
Adults with type 1 and type 2 diabetes should aim to spend more than 70% of each day in the target range of 70 to 180 mg/dL (3.9 to 10.0 mmol/L), which corresponds to an HbA1c level of about 7%, the consensus report said.
https://diabetes.acponline.org/archives/2019/06/14/1.htm
14 Jun 2019
Intensive BP control reduced long-term CV risk, new ACCORD follow-up finds
After four years of follow-up, patients who had received intensive treatment during the trial had similar systolic blood pressure (BP) to those who had been on standard treatment but lower rates of cardiovascular (CV) events.
https://diabetes.acponline.org/archives/2018/03/09/2.htm
9 Mar 2018
Screening recommended to detect metabolic risk for ASCVD, type 2 diabetes
The Endocrine Society recently updated its guidance on primary prevention of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes in those at metabolic risk.
https://diabetes.acponline.org/archives/2019/08/09/1.htm
9 Aug 2019
Impaired glucose tolerance at 1 hour may be more predictive than at 2 hours, study finds
The results highlight the potential benefit of targeting individuals with an elevated one-hour blood glucose level and, if supported by additional evidence, eventually replacing the two-hour test with a one-hour measure, the authors said.
https://diabetes.acponline.org/archives/2017/12/08/2.htm
8 Dec 2017
Beta-blockers associated with mortality risk in patients with diabetes, study finds
Patients with diabetes who were taking any beta-blocker, a beta-1 selective beta-blocker, or a specific beta-blocker had significantly higher risk for all-cause mortality versus patients with diabetes who were not taking a beta-blocker.
https://diabetes.acponline.org/archives/2018/04/13/2.htm
13 Apr 2018
Benefits of gastric bypass may diminish after 5 years
Patients with type 2 diabetes who had Roux-en-Y gastric bypass surgery maintained significant, although shrinking, improvements in HbA1c compared to those receiving lifestyle and medical management.
https://diabetes.acponline.org/archives/2018/02/09/2.htm
9 Feb 2018
Sociodemographic, clinical factors may influence insulin initiation in type 2 diabetes
The researchers found an inverse association between insulin initiation and age, and black and Hispanic participants were less likely to have insulin initiated compared with white participants.
https://diabetes.acponline.org/archives/2018/02/09/3.htm
9 Feb 2018
Cardiovascular benefits of adding ezetimibe to statin therapy may be greater in patients with diabetes, study finds
Participants were randomized to receive either ezetimibe or placebo in addition to background simvastatin, and the subgroup of patients with diabetes was compared to those without the disease.
https://diabetes.acponline.org/archives/2018/01/12/2.htm
12 Jan 2018
Individualizing glycemic control could reduce costs, increase quality-adjusted life-years
A cost-effectiveness analysis found that individualized control saved $13,547 per patient compared with uniform intensive control, primarily due to lower medication costs, and increased quality-adjusted life-years by 0.10.
https://diabetes.acponline.org/archives/2018/01/12/3.htm
12 Jan 2018